The Lu subtype mostly represents oestrogen receptor/ER-positive BCs that may or may not be progesterone receptor/PR- and/or HER2-positive tumours, whereas the B subtype lacks the expression of these receptors, and is often designated ‘triple-negative’ (Andre and Pusztai, 2006). Here, PGR is linked to neoplasm.